Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...
Positive results from the POTOMAC Phase III trial showed adding one year of treatment with AstraZeneca’s IMFINZI® (durvalumab) to BCG induction and maintenance therapy demonstrated a statistically ...
To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...
CG Oncology Inc. (NASDAQ:CGON) is one of the best hot stocks to invest in. On October 8, Guggenheim analyst Brad Canino ...
A novel drug-delivery system has demonstrated effectiveness in treating specific bladder cancer patients whose tumors ...
Discover a study exploring how bladder cancer organoids advance personalised drug testing, reveal tumour heterogeneity, and ...
Petros Grivas, MD, PhD, discusses the overall survival and quality-of-life findings from the JAVELIN Bladder 100 trial of ...
News-Medical.Net on MSN
Smoking and sex found to shape early cellular changes linked to bladder cancer
Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, ...
Discover the most anticipated abstracts on renal cell carcinoma and bladder cancer at the 2025 ESMO Congress in Berlin. With the 2025 European Society of Medical Oncology (ESMO) Congress starting on ...
Deion Sanders recalled the intense pain he suffered while recovering after his bladder removal surgery during an appearance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback